Sign in

NCT05852002Completed

A Clinical Study of Pain and Discomfort Associated With Advanced Lung Cancer

A Clinical Study of 35 kDa Hyaluronan Fragment in Treatment of Pain and Discomfort Associated With Advanced Lung Cancer

Source: ClinicalTrials.gov · Last updated 17 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In this research, the patients with advanced lung cancer accompanied by pain and discomfort were treated by injecting freshly manufactured tissue permeable hyaluronan fragment HA35 into the tissue under abdominal adipose.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
1 May 2023
Start date
11 Apr 2023
Primary completion date
1 Nov 2023
Lead sponsor
Nakhia Impex LLC
Diseases
Lung cancer
NCT number
NCT05852002

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 11 Apr 2023 to the primary completion date, 1 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects who are receiving systematic steroid treatments before the first cell treatment.

Other illness

  • Subjects with a history of mental disorders or drug abuse that may influence treatment compliance.

Other

  • Women in pregnancy or lactation or are expected to be pregnant during the study.

Who the study is looking for

  • Age\>=18 years old
  • Sign the informed consent form voluntarily.
  • Expected survival ≥3 months.
  • Pathologically confirmed locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), which is currently not suitable for local treatment such as radical surgery or radiotherapy.
  • The subject has good compliance and cooperates with the follow-up.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mongolian National University of Medical Sciences
Coordinator of this site? Confirm its status
UlaanbaatarMongoliaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.